Raxibacumab

N/A

Report date: 2022/02/11 15:37:54
First In Class

Base Information

Drug NameRaxibacumab
Drug Alias NameRaxibacumabum雷昔巴库单抗PA mAb雷昔库单抗瑞西巴库 +[11] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAntrax lethal toxin inhibitors
TargetsAntrax lethal toxin
Therapy Area/IndicationsAnthrax
Global Approved IndicationsAnthrax
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/12/14
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesHuman Genome Sciences Inc
Inactive CompaniesN/A
Active IndicationsAnthrax
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB18
Related LinksWikipediaDrugBankKEGG